ACADIA Pharmaceuticals Inc. Financial Ratios — ACAD Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-85.82	-38.49	-28.41	-37.62	-64.58	-75.58	-67.8	-60.22	-39.93	-42.47	-28.75	-45.89	-14.73	38.89	39.89
Return on Assets (%)	-64.57	-29.64	-25.49	-35.94	-60.09	-69.32	-61.21	-53.03	-35.55	-35.97	-22.64	-33.54	-9.17	23.39	28.42
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	35.56	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.49	- -
Gross Margin (%)	100	100	100	100	-3,998.36	74.58	89.54	91.81	94.22	95.35	96.05	98.03	94.27	91.46	91.69
EBITDA Margin (%)	-1,091.78	-423.42	-3,337.82	-77,520	-268,795.08	-1,563.6	-231.94	-109.22	-71.9	-64.21	-34.51	-42.84	-9.34	10.46	10.88
Operating Margin (%)	-1,105.56	-425.64	-3,344.72	-77,691.67	-269,855.74	-1,574.14	-234.11	-110.56	-72.71	-64.87	-35.2	-43.23	-10.1	8.8	9.78
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	68.14	18.06
Pretax Margin (%)	-1,101.35	-424.88	-3,314.24	-77,062.5	-269,037.7	-1,558.2	-230.81	-108.99	-69.12	-63.6	-34.6	-41.27	-7.03	26.94	12.96
Profit Margin (%)	-1,101.35	-424.88	-3,314.24	-77,062.5	-269,578.69	-1,565.94	-231.71	-109.56	-69.38	-63.74	-34.67	-41.76	-8.44	23.64	36.49
Net Income to Common Margin (%)	-1,101.35	-424.88	-3,314.24	-77,062.5	-269,578.69	-1,565.94	-231.71	-109.56	-69.38	-63.74	-34.67	-41.76	-8.44	23.64	36.49
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.25	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-85.82	-38.49	-28.41	-37.62	-64.58	-75.58	-67.8	-60.22	-39.93	-42.47	-28.75	-45.89	-14.73	38.89	39.89

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	10	50	64	62	57	52	52
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	3	5	8	9	9	10	12
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	6	44	56	53	48	42	41
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.04	-0.17	-0.39	-0.28	-0.84	0.52	0.45
Net Debt/EBITDA	0.3	2.79	0.31	0.66	0.62	0.6	0.24	0.55	0.78	1.15	0.88	0.52	2.78	-3.19	-1.52
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.04	-0.17	-0.38	-0.28	-0.78	0.62	0.5
Net Debt/EBIT	0.3	2.77	0.31	0.66	0.62	0.6	0.24	0.54	0.77	1.14	0.87	0.51	2.57	-3.79	-1.7
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	72.75	78.26	96.31	95.09	90.03	92.38	87.2	88.69	89.27	80.12	77.26	68.12	57.65	61.7	78.47
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.91	7.09	10.38	13.16	11.07	5.74	3.3
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.9	6.57	9.27	11.4	9.78	5.36	3.17
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.81	5.68	8.02	8.96	6.38	3.54	2.59
Total Debt/Equity (%)	0.14	- -	- -	- -	- -	- -	- -	- -	1.4	7.9	11.91	15.48	13.25	7.1	4.25
Total Debt/Capital (%)	0.14	- -	- -	- -	- -	- -	- -	- -	1.38	7.32	10.64	13.41	11.7	6.63	4.08
Total Debt/Total Assets (%)	0.1	- -	- -	- -	- -	- -	- -	- -	1.25	6.33	9.2	10.55	7.64	4.38	3.34
Net Debt to Equity	-29.35	-68.13	-6.43	-19.99	-51.13	-31.56	-20.7	-28.13	-27.13	-52	-27.26	-28.68	-43.7	-43.61	-14.48
Net Debt/Capital (%)	-41.54	-213.77	-6.87	-24.98	-104.62	-46.12	-26.11	-39.14	-36.53	-93.01	-32.2	-33.04	-62.82	-68.7	-16.13
EBITDA	-23	-21	-38	-93	-164	-271	-290	-244	-244	-284	-167	-222	-68	100	117
EBITDA-CapEx	-23	-21	-39	-93	-166	-280	-291	-247	-245	-291	-168	-222	-68	100	112
Operating Income (Loss)	-23	-21	-38	-93	-165	-273	-292	-247	-247	-287	-170	-224	-73	84	105

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	5.04	18.15	26.62	20.37	9.82	12.42	6.96	7.95	9.32	5.96	5.42	3.32	1.73	1.91	2.96
Current Ratio	5.18	18.25	26.99	20.5	10	12.87	7.62	8.83	10.16	6.77	6.43	4.04	2.42	2.38	3.83
Quick Ratio	5.04	18.15	26.73	20.43	9.9	12.59	7.34	8.42	9.83	6.44	6.1	3.82	2.13	2.18	3.49
CFO/Avg Current Liab	-3.28	-3.57	-4.92	-5.82	-6.46	-6.46	-4.75	-3.08	-2.25	-1.51	-1.24	-1.03	0.09	0.49	0.33
Common Equity/Total Assets	72.75	78.26	96.31	95.09	90.03	92.38	87.2	88.69	89.27	80.12	77.26	68.12	57.65	61.7	78.47
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.91	7.09	10.38	13.16	11.07	5.74	3.3
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.9	6.57	9.27	11.4	9.78	5.36	3.17
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.81	5.68	8.02	8.96	6.38	3.54	2.59
Total Debt/Equity (%)	0.14	- -	- -	- -	- -	- -	- -	- -	1.4	7.9	11.91	15.48	13.25	7.1	4.25
Total Debt/Capital (%)	0.14	- -	- -	- -	- -	- -	- -	- -	1.38	7.32	10.64	13.41	11.7	6.63	4.08
Total Debt/Total Assets (%)	0.1	- -	- -	- -	- -	- -	- -	- -	1.25	6.33	9.2	10.55	7.64	4.38	3.34
CFO/Total Liabilities	-227.34	-91.64	-454.69	-416.02	-550.26	-487.6	-442.41	-273.99	-179.81	-87.51	-78.92	-60.85	5.27	34.67	32.61
CFO/CapEx	-6,632.33	- -	-51.41	-369.08	-56.89	-21.92	-268.17	-79.6	-133.86	-17.95	-112	- -	334.04	301.57	23.42
Altman's Z-Score	-12.53	4.47	192.99	117.4	92.95	46.28	39.95	18.94	44.81	29.64	10.64	3.02	6.12	2.91	7.98

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	- -	- -	- -	- -	5.87	10.75	10.31	10.96	10.51	8.6	8.17	9.05	9.72	9.73
Days Sales Outstanding	- -	- -	- -	- -	- -	62.16	33.97	35.42	33.3	34.71	42.45	44.66	40.31	37.54	37.5
Inventory Turnover	- -	- -	- -	- -	- -	2.11	2.77	3.93	3.76	2.57	2.18	1.4	1.96	2.83	3.14
Days Inventory Outstanding	- -	- -	- -	- -	- -	172.93	131.68	92.77	96.95	142.3	167.45	260.61	186.08	128.82	116.1
Accounts Payable Turnover	- -	- -	- -	- -	1.36	3.07	2.23	2.87	4.21	3.04	2.26	0.91	4.68	4.03	7.51
Accounts Payable Turnover Days	- -	- -	- -	- -	269.22	118.76	163.97	127.18	86.7	120.04	161.76	401.41	78.05	90.58	48.61
Cash Conversion Cycle	- -	- -	- -	- -	-269.22	116.33	1.67	1.01	43.55	56.97	48.15	-96.15	148.34	75.78	104.99
Inventory to Cash Days	- -	- -	- -	- -	- -	-110.77	-97.71	-57.36	-63.65	-107.58	-125	-215.95	-145.77	-91.28	-78.6
Inventories	- -	- -	- -	- -	- -	4	5	4	6	10	8	7	36	22	35
Raw Materials	- -	- -	- -	- -	- -	2	4	2	1	2	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	2	6	7	4	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	2	1	1	3	1	1	2	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	36	22	35

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	57	341	2,277	3,177	3,634	3,500	3,746	2,326	6,643	8,534	3,758	2,580	5,155	3,059	4,549
- Cash & Cash Equivalents	7	58	12	62	102	164	69	135	190	326	147	115	189	320	178
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	10	50	64	62	57	52	52
Enterprise Value	26	233	2,091	2,854	3,419	2,971	3,405	1,853	5,955	7,952	3,302	2,225	4,774	2,355	3,781
Total Capital	23	85	182	309	200	518	335	479	709	677	605	462	489	785	1,280
Total Debt/Capital (%)	0.14	- -	- -	- -	- -	- -	- -	- -	1.38	7.32	10.64	13.41	11.7	6.63	4.08
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.02	0.03	0.01	0.02	0.01
EV/Sales	12.63	47.49	1,826.08	23,783.47	56,048.9	171.44	27.26	8.28	17.56	18	6.82	4.3	6.57	2.46	3.53
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.51	32.44
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.94	36.08
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	285.81	14.93	34.43
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	284.95	14.88	33.02
Diluted Market Cap	56	256	2,142	3,088	3,587	3,341	3,691	2,047	6,297	8,411	3,746	2,574	5,129	3,053	4,539
Diluted Enterprise Value	50	198	2,130	3,026	3,485	3,178	3,622	1,912	6,117	8,134	3,663	2,521	4,998	2,785	4,413
EV per Share	0.49	3.18	22.95	28.53	33.54	24.48	27.37	12.88	38.35	49.81	20.51	13.73	28.99	14.13	22.2
TTM Sales	2	5	1	- -	- -	17	125	224	339	442	484	517	726	958	1,072
TTM EBITDA	-23	-21	-38	-93	-164	-271	-290	-244	-244	-284	-167	-222	-68	100	117
TTM Operating Income	-23	-21	-38	-93	-165	-273	-292	-247	-247	-287	-170	-224	-73	84	105
TTM Cash Flow to Firm	-20	-22	-32	-66	-122	-208	-218	-167	-151	-136	-126	-114	17	158	110
TTM Free Cash Flow to Firm	-20	-22	-31	-66	-120	-199	-217	-165	-150	-129	-125	-114	17	158	115

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-2.83	-11.85	-68.76	-46.6	-29.98	-16.8	-17.02	-12.38	-41.98	-65.41	-30.08	-22.57	306.18	19.29	39.63
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	27.94	36.08
Enterprise Value	26	233	2,091	2,854	3,419	2,971	3,405	1,853	5,955	7,952	3,302	2,225	4,774	2,355	3,781
Low Price	0.9	1.07	4.6	15.64	29.45	16.64	25.06	12.77	15.73	30.02	15.68	12.24	15.77	14.15	13.4
EV/Sales	12.63	47.49	1,826.08	23,783.47	56,048.9	171.44	27.26	8.28	17.56	18	6.82	4.3	6.57	2.46	3.53
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	23.51	32.44
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.43	11.5
Price/Earnings Average	-3.51	-5.49	-36.73	-25.75	-22.95	-12.38	-13.72	-10.38	-19.26	-25.44	-25.15	-13.96	-61.74	13.44	9.1
Price/Earnings High	-7.56	-17.29	-67.15	-35.22	-31.81	-18.14	-17.45	-17.03	-33.6	-32.81	-53.4	-21.01	-90.86	23.29	12.21
Price/Earnings Low	-2.06	-2.83	-10.39	-16.45	-18.02	-7.1	-10.62	-6.59	-9.84	-16.77	-14.99	-9.16	-42.15	10.35	5.77
Price/Book Value	2.45	4.01	12.5	10.26	18.19	6.75	11.17	4.86	9.5	13.61	6.95	6.44	11.94	4.17	3.71
Price/Book Value Average	3.46	1.79	8.13	7.91	19.14	6.79	12.02	6.03	6.84	11.59	7.83	7.55	8.81	4.18	2.93
Price/Book Value High	7.47	5.64	14.87	10.83	26.53	9.95	15.29	9.91	11.93	14.95	16.63	11.36	12.96	7.24	3.93
Price/Book Value Low	2.04	0.92	2.3	5.06	15.03	3.9	9.3	3.83	3.49	7.64	4.67	4.95	6.01	3.22	1.86
Price/Tangible Book Value	2.45	4.01	12.5	10.26	18.19	6.84	11.36	4.9	9.54	13.64	6.95	6.44	14.08	4.99	4.07
Price/Tangible Book Value Average	3.46	1.79	8.13	7.91	19.14	6.88	12.22	6.09	6.86	11.61	7.83	7.55	10.38	5	3.22
Price/Tangible Book Value High	7.47	5.64	14.87	10.83	26.53	10.08	15.54	9.99	11.97	14.98	16.63	11.36	15.28	8.65	4.32
Price/Tangible Book Value Low	2.04	0.92	2.3	5.06	15.03	3.95	9.45	3.87	3.51	7.66	4.67	4.95	7.09	3.85	2.04
Price/Sales	27.27	52.23	1,870.76	25,730.2	58,810.81	192.8	29.56	9.15	18.57	19.04	7.74	4.98	7.06	3.17	4.2
Price/Sales Average	38.61	23.35	1,217.42	19,842.1	61,881.17	193.93	31.79	11.37	13.37	16.22	8.72	5.83	5.21	3.18	3.32
Price/Sales High	83.31	73.46	2,225.6	27,140.3	85,766.45	284.05	40.44	18.66	23.31	20.91	18.51	8.77	7.67	5.51	4.45
Price/Sales Low	22.72	12.02	344.36	12,674.66	48,582.84	111.24	24.6	7.22	6.83	10.69	5.2	3.83	3.56	2.45	2.11
Price/Cash Flow	-2.83	-11.85	-67.42	-46.48	-29.45	-16.03	-16.95	-12.22	-41.67	-61.77	-29.81	-22.57	307.1	19.28	40.94
Price/Cash Flow Average	-4.01	-5.3	-43.88	-35.84	-30.99	-16.13	-18.24	-15.19	-29.99	-52.61	-33.59	-26.43	226.56	19.3	32.41
Price/Cash Flow High	-8.65	-16.66	-80.21	-49.02	-42.96	-23.62	-23.2	-24.94	-52.3	-67.85	-71.33	-39.78	333.39	33.43	43.45
Price/Cash Flow Low	-2.36	-2.73	-12.41	-22.89	-24.33	-9.25	-14.11	-9.65	-15.32	-34.69	-20.03	-17.35	154.68	14.87	20.54
Price/Free Cash Flow Average	-4.01	-5.3	-44.75	-35.94	-31.55	-16.9	-18.3	-15.38	-30.21	-55.71	-33.9	-26.43	225.88	19.31	31.37
Price/Free Cash Flow High	-8.66	-16.66	-81.8	-49.16	-43.72	-24.75	-23.28	-25.25	-52.7	-71.85	-71.97	-39.78	332.39	33.45	42.06
Price/Free Cash Flow Low	-2.36	-2.73	-12.66	-22.96	-24.77	-9.69	-14.16	-9.78	-15.44	-36.73	-20.21	-17.35	154.22	14.88	19.88
EV/Sales Average	35.82	19.26	1,283.71	19,897.81	61,011.54	193.71	31.71	12.32	13.57	15.83	8.58	5.74	5.05	2.92	3.24
EV/Sales High	81.14	85.94	2,355.26	27,406.09	85,207.46	288.11	40.48	20.6	24.06	20.59	18.4	8.69	7.52	5.26	4.39
EV/Sales Low	19.72	4.19	355.78	12,524.05	47,540.27	107.09	24.41	7.61	6.67	10.22	5.04	3.73	3.39	2.18	2.01
EV/EBITDA Average	-3.28	-4.55	-38.46	-25.67	-22.7	-12.39	-13.67	-11.28	-18.87	-24.65	-24.85	-13.4	-54.13	27.9	29.81
EV/EBITDA High	-7.43	-20.3	-70.56	-35.35	-31.7	-18.43	-17.45	-18.86	-33.47	-32.07	-53.32	-20.29	-80.57	50.29	40.34
EV/EBITDA Low	-1.81	-0.99	-10.66	-16.16	-17.69	-6.85	-10.52	-6.96	-9.28	-15.92	-14.61	-8.71	-36.34	20.88	18.5
EV/EBIT Average	-3.24	-4.53	-38.38	-25.61	-22.61	-12.31	-13.54	-11.14	-18.66	-24.4	-24.36	-13.28	-50.04	33.16	33.16
EV/EBIT High	-7.34	-20.19	-70.42	-35.28	-31.58	-18.3	-17.29	-18.63	-33.09	-31.74	-52.27	-20.1	-74.48	59.77	44.87
EV/EBIT Low	-1.78	-0.98	-10.64	-16.12	-17.62	-6.8	-10.42	-6.88	-9.18	-15.76	-14.33	-8.64	-33.59	24.81	20.58
Last Price	1.08	4.65	24.99	31.75	35.65	28.84	30.11	16.17	42.78	53.46	23.34	15.92	31.31	18.35	26.71
High Price	3.3	6.54	29.73	33.49	51.99	42.49	41.2	32.99	53.7	58.72	55.85	28.06	33.99	31.82	28.35
Enterprise Value Average	74	95	1,470	2,388	3,722	3,357	3,960	2,756	4,601	6,992	4,152	2,969	3,672	2,794	3,475
Enterprise Value High	168	422	2,697	3,289	5,198	4,993	5,056	4,611	8,158	9,097	8,910	4,495	5,465	5,037	4,703
Enterprise Value Low	41	21	407	1,503	2,900	1,856	3,048	1,702	2,263	4,516	2,442	1,931	2,465	2,091	2,157

Shares Outstanding	53	73	91	100	102	121	124	144	155	160	161	162	165	167	170
Diluted Weighted Avg Shares	52	55	86	97	101	116	123	127	147	157	160	162	164	166	170
Basic Weighted Avg Shares	52	55	86	97	101	116	123	127	147	157	160	162	164	166	168
Revenue per Share	0.04	0.09	0.01	- -	- -	0.15	1.02	1.77	2.3	2.81	3.02	3.2	4.43	5.78	6.36
EBITDA per Share	-0.43	-0.38	-0.45	-0.96	-1.63	-2.34	-2.36	-1.93	-1.66	-1.8	-1.04	-1.37	-0.41	0.6	0.69
Operating Income per Share	-0.44	-0.38	-0.45	-0.96	-1.64	-2.35	-2.39	-1.95	-1.67	-1.82	-1.06	-1.38	-0.45	0.51	0.62
Basic EPS, GAAP	-0.44	-0.38	-0.44	-0.95	-1.63	-2.34	-2.36	-1.94	-1.6	-1.79	-1.05	-1.34	-0.37	1.37	2.32
Basic EPS from Cont Ops	-0.44	-0.38	-0.44	-0.95	-1.63	-2.34	-2.36	-1.94	-1.6	-1.79	-1.05	-1.34	-0.37	1.37	2.32
Diluted EPS, GAAP	-0.44	-0.38	-0.44	-0.95	-1.63	-2.34	-2.36	-1.94	-1.6	-1.79	-1.05	-1.34	-0.37	1.36	2.3
Diluted EPS from Cont Ops	-0.44	-0.38	-0.44	-0.95	-1.63	-2.34	-2.36	-1.94	-1.6	-1.79	-1.05	-1.34	-0.37	1.36	2.3
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.38	-0.39	-0.37	-0.68	-1.21	-1.8	-1.78	-1.32	-1.03	-0.87	-0.78	-0.71	0.1	0.95	0.65
Free Cash Flow per Basic Share	-0.38	-0.39	-0.38	-0.68	-1.23	-1.88	-1.78	-1.34	-1.03	-0.91	-0.79	-0.71	0.1	0.95	0.62
Cash & Equivalents per Share	0.59	1.47	2.04	3.22	2.11	4.36	2.74	3.29	4.49	3.96	3.23	2.57	2.67	4.53	4.81
Book Value per Share	0.44	1.16	2	3.09	1.96	4.27	2.69	3.33	4.5	3.93	3.36	2.47	2.62	4.4	7.21
Tangible Book Value per Share	0.44	1.16	2	3.09	1.96	4.21	2.65	3.3	4.49	3.92	3.36	2.47	2.22	3.68	6.57

ACADIA Pharmaceuticals Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)